Add like
Add dislike
Add to saved papers

Effects of transcutaneous electrical nerve stimulation in patients with peripheral and central neuropathic pain.

OBJECTIVE: To evaluate and compare the effects of transcutaneous electrical nerve stimulation (TENS) therapy on pain intensity and functional capacity in patients with either peripheral neuropathic pain or central neuropathic pain.

METHODS: A total of 40 patients (20 with peripheral neuropathic pain and 20 with central neuropathic pain) were included in this study. Pain severity, pain quality, and functional capacity were assessed with a visual analogue scale, a neuropathic pain scale, and the Brief Pain Inventory, respectively. A pre-post-treatment design was used. Semmes Weinstein monofilaments were used to evaluate touch sensation. Mild pressure was applied to provoke static mechanical allodynia. The presence of any severe and sharp pains upon pricking was considered a positive sign for hyperalgesia. The 2 groups of patients received 20/30-min sessions of TENS therapy over 4 weeks.

RESULTS: No significant differences were found between the 2 groups regarding the pre-treatment values for visual analogue scale, neuropathic pain scale, and Brief Pain Inventory. The pain parameters in both groups were significantly decreased by TENS therapy for 4 weeks (p < 0.05). The group with peripheral neuropathic pain presented more overall improvements than the group with central neuropathic pain (p < 0.05).

CONCLUSION: TENS therapy can be used successfully in clinical practice as an alternative or supportive treatment.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app